Lantern Pharma Inc. LTRN
Regular-session close
After hours · Nov 20, 4:26 PM ET
- YTD
- -91.91%
- 1 year
- -91.83%
Held by funds
6 US ETFs and mutual funds hold LTRN · largest positions
Ownership
- Institutions 24.1%
- Insiders 14.7%
- Public and other holders 61.2%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.37% | 363,720 | 1.10M | Sep 29, 2024 |
| CM Management, LLC | 1.72% | 185,000 | 558.70K | Sep 29, 2024 |
| NewEdge Advisors, LLC | 1.27% | 137,338 | 414.76K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.81% | 87,435 | 264.05K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.78% | 84,000 | 253.68K | Sep 29, 2024 |
| Davenport & Co LLC | 0.50% | 53,814 | 162.52K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.37% | 256,113 | 773.46K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.92% | 99,265 | 299.78K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.43% | 46,104 | 139.23K | Oct 30, 2024 |
| Listed Funds Tr-Horizon Kinetics Medical ETF | 0.26% | 27,582 | 83.30K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.16% | 16,782 | 50.68K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 15,440 | 46.63K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs LTRN, and what each was last paid
Panna Sharma, President, Chief Executive Officer & DirectorAverage age 64
| Name | Title | Pay | Age |
|---|---|---|---|
| Panna Sharma | President, Chief Executive Officer & Director | $764K | 55 |
| David R. Margrave | Chief Financial Officer & Secretary | $541K | 65 |
| Kishor Gopaldas Bhatia | Chief Scientific Officer & Scientific Consultant | $222K | 71 |
| Marc C. Chamberlain | Chief Medical Officer of Starlight Therapeutics | — | — |
| Peter L. Nara | Co-Founder & Advisor | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FLETCHER AARON G.L. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 16, 2024 | 0 |
| KEYSER DONALD JEFFREY PH.D | Director | Conversion of Exercise of derivative security | Jul 23, 2024 | 0 |
| KREIS LESLIE W JR | Beneficial Owner of more than 10% of a Class of Security | Sale | May 23, 2024 | 0 |
